Question 1

What is NewAmsterdam Pharma?

Accepted Answer

NewAmsterdam Pharma is a Company.

Question 2

How often does NewAmsterdam Pharma appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 39 articles.

Question 3

When was NewAmsterdam Pharma first tracked by Ergen?

Accepted Answer

First tracked on Jul 07, 2026.

Question 4

When was NewAmsterdam Pharma last mentioned in news?

Accepted Answer

Last active on Jul 14, 2026.

Question 5

What is NewAmsterdam Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 45 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is NewAmsterdam Pharma in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving NewAmsterdam Pharma?

Accepted Answer

Cambrex wins Green Chemistry Award (Jul 06, 2026, 17 articles).

Question 8

How did the "Cambrex wins Green Chemistry Award" event impact NewAmsterdam Pharma?

Accepted Answer

NewAmsterdam Pharma collaborated on the process for obicetrapib, potentially reducing its manufacturing costs and advancing its drug candidate.

Question 9

How did the "Biogen diranersen tau-targeting Alzheimer's trial" event impact NewAmsterdam Pharma?

Accepted Answer

NewAmsterdam plans to study obicetrapib for Alzheimer's risk in APOE4 carriers, potentially expanding its drug's indications.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.